Alembic Pharmaceuticals Ltd (APLLTD) is currently trading at 796.95 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Alembic Pharmaceuticals Limited is a global manufacturer and marketer of generic pharmaceutical products. The company reported a 16% year-over-year revenue growth for Q2 FY26, driven by a strong performance in international markets including the US and Ex-US generics. Alembic's US generics business grew 21% YoY, supported by key product launches and market share gains, underscoring its strategic focus on expanding its footprint in the US pharmaceutical market. The Ex-US generics business saw an impressive 31% YoY growth, driven by targeted execution and strong customer demand across key markets including Europe and Canada. The company's acquisition of Utility Therapeutics marks its entry into the US branded market, highlighting its strategic intent to tap into new revenue streams through mergers and acquisitions. Alembic's R&D investment represents 10% of its revenue, reflecting a strong commitment to building a pipeline of high-value products, especially in complex and specialty divisions.

Over the past 52 weeks, Alembic Pharmaceuticals Ltd has traded between a low of ₹725.60 and a high of ₹1,107.80. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Alembic Pharmaceuticals Ltd has a market capitalization of approximately 15,706.38. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Alembic Pharmaceuticals Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 23.61 and operates in the Pharmaceuticals sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

You can buy shares of Alembic Pharmaceuticals Ltd (APLLTD) through any SEBI-registered stockbroker in India. A demat and trading account are required to place buy or sell orders on stock exchanges such as NSE or BSE. Shares are credited to the demat account as per the exchange settlement cycle.

Based on its market capitalization of 15,706.38 Cr, Alembic Pharmaceuticals Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Alembic Pharmaceuticals Ltd operates in the Pharmaceuticals sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Alembic Pharmaceuticals Ltd is 23.61. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Alembic Pharmaceuticals Ltd pays dividends with a current dividend yield of 1.38%. Dividend-paying stocks may provide periodic income in addition to potential long-term capital appreciation.

Key risks associated with Alembic Pharmaceuticals Ltd include sector-specific challenges in the Pharmaceuticals industry, regulatory changes, competitive pressures, company-level financial performance, overall market volatility, and broader macroeconomic factors that can impact stock prices.